J. PAUL LOCK, M.D.; GLORIA A. M. CASTRO, M.D.; LIBERTO N. PECHET, M.D.; L. MICHAEL SNYDER, M.D.
This content is PDF only. Please click on the PDF icon to access.
To the editor: Drs. Leech, Polesky, and Shapiro (1) recently reported on chronic hemodialysis as palliative therapy to prolong the useful life span of two patients with meyelomatosis presenting primarily as renal failure. We have recently successfully treated a patient with multiple myeloma with prolonged intermittent peritoneal dialysis for acute and chronic renal failure associated with hypercalcemia and hyperuricemia. The judicious use of peritoneal dialysis carried the patient through a critical period and allowed time for chemotherapy to be effective and the patient to enter remission.
A 71-year-old man entered the hospital because of a history of 2 months of
LOCK JP, CASTRO GAM, PECHET LN, SNYDER LM. Hemodialysis in Myelomatosis. Ann Intern Med. 1973;78:454. doi: 10.7326/0003-4819-78-3-454_1
Download citation file:
Published: Ann Intern Med. 1973;78(3):454.
Hematology/Oncology, Multiple Myeloma, Nephrology, Renal Replacement Therapy.
Results provided by:
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use